220 related articles for article (PubMed ID: 26882815)
1. The Evaluation of Serum Pentraxin-3 and High-Sensitivity C-Reactive Protein Levels in Patients with Acute Attack of COPD.
Duran L; Unsal M; Yardan T; Kati C; Bedir A; Turkeli S; Ekiz M
Clin Lab; 2015; 61(12):1911-6. PubMed ID: 26882815
[TBL] [Abstract][Full Text] [Related]
2. Pentraxin 3 as a novel biomarker of inflammation in chronic obstructive pulmonary disease.
Kurt OK; Tosun M; Kurt EB; Talay F
Inflammation; 2015 Feb; 38(1):89-93. PubMed ID: 25303877
[TBL] [Abstract][Full Text] [Related]
3. The role of pentraxin3 in plasma and bronchoalveolar lavage fluid in COPD patients with invasive pulmonary aspergillosis.
He Q; Zhang M; Feng C
BMC Pulm Med; 2021 Dec; 21(1):414. PubMed ID: 34915889
[TBL] [Abstract][Full Text] [Related]
4. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
Long H; Luo H; Chen P; Li Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
6. Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD.
Thulborn SJ; Dilpazir M; Haldar K; Mistry V; Brightling CE; Barer MR; Bafadhel M
Int J Chron Obstruct Pulmon Dis; 2017; 12():1199-1205. PubMed ID: 28458531
[TBL] [Abstract][Full Text] [Related]
7. Plasma Pentraxin 3, but not high-sensitivity C-reactive protein, is a useful inflammatory biomarker for predicting cognitive impairment in elderly hypertensive patients.
Yano Y; Matsuda S; Hatakeyama K; Sato Y; Imamura T; Shimada K; Kodama T; Kario K; Asada Y
J Gerontol A Biol Sci Med Sci; 2010 May; 65(5):547-52. PubMed ID: 20203097
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of systemic pentraxin 3 are associated with thin-cap fibroatheroma in coronary culprit lesions: assessment by optical coherence tomography and intravascular ultrasound.
Koga S; Ikeda S; Yoshida T; Nakata T; Takeno M; Masuda N; Koide Y; Kawano H; Maemura K
JACC Cardiovasc Interv; 2013 Sep; 6(9):945-54. PubMed ID: 23954061
[TBL] [Abstract][Full Text] [Related]
9. Pentraxin 3 Gene Polymorphisms and Pulmonary Aspergillosis in Chronic Obstructive Pulmonary Disease Patients.
He Q; Li H; Rui Y; Liu L; He B; Shi Y; Su X
Clin Infect Dis; 2018 Jan; 66(2):261-267. PubMed ID: 29020397
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein levels in stable COPD patients: a case-control study.
Silva DR; Gazzana MB; Knorst MM
Int J Chron Obstruct Pulmon Dis; 2015; 10():1719-25. PubMed ID: 26357470
[TBL] [Abstract][Full Text] [Related]
11. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study of Pentraxin 3 in diagnosing the severity and cardiovascular function of the children with sepsis].
Kang X; Zhu Y; Zhang X
Zhonghua Er Ke Za Zhi; 2015 Aug; 53(8):592-8. PubMed ID: 26717657
[TBL] [Abstract][Full Text] [Related]
13. Echocardiography, spirometry, and systemic acute-phase inflammatory proteins in smokers with COPD or CHF: an observational study.
Beghé B; Verduri A; Bottazzi B; Stendardo M; Fucili A; Balduzzi S; Leuzzi C; Papi A; Mantovani A; Fabbri LM; Ceconi C; Boschetto P
PLoS One; 2013; 8(11):e80166. PubMed ID: 24244639
[TBL] [Abstract][Full Text] [Related]
14. Acute phase reactant, Pentraxin 3, as a novel marker for the diagnosis of rheumatoid arthritis.
Sharma A; Khan R; Gupta N; Sharma A; Zaheer MS; Abbas M; Khan SA
Clin Chim Acta; 2018 May; 480():65-70. PubMed ID: 29408170
[TBL] [Abstract][Full Text] [Related]
15. Relationship between airway obstruction and C-reactive protein levels in a community-based population of Korea.
Yoo B; Lee SH; Kim SY; Leem AY; Chung KS; Kim EY; Jung JY; Kang YA; Park MS; Chang J; Kim YS; Park Y
Int J Tuberc Lung Dis; 2019 Nov; 23(11):1228-1234. PubMed ID: 31718761
[No Abstract] [Full Text] [Related]
16. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
[TBL] [Abstract][Full Text] [Related]
17. Driver mutations (JAK2V617F, MPLW515L/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera.
Lussana F; Carobbio A; Salmoiraghi S; Guglielmelli P; Vannucchi AM; Bottazzi B; Leone R; Mantovani A; Barbui T; Rambaldi A
J Hematol Oncol; 2017 Feb; 10(1):54. PubMed ID: 28228104
[TBL] [Abstract][Full Text] [Related]
18. Plasma pentraxin 3 is associated with cardiovascular disease in hemodialysis patients.
Xu Y; Ding X; Zou J; Liu Z; Jiang S; Xu S; Shen B; Chen Y; Shan Y; Cao X
Ren Fail; 2011; 33(10):998-1004. PubMed ID: 22013933
[TBL] [Abstract][Full Text] [Related]
19. The Diagnostic and Assessment Value of Plasma Pentraxin 3 in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Gu Y; Li P; Xiao Y; Zhang J; Su X
Int J Chron Obstruct Pulmon Dis; 2023; 18():1391-1400. PubMed ID: 37456914
[TBL] [Abstract][Full Text] [Related]
20. COPD is associated with reduced pulmonary interstitial expression of pentraxin-3.
Van Pottelberge GR; Bracke KR; Pauwels NS; Vermassen FE; Joos GF; Brusselle GG
Eur Respir J; 2012 Apr; 39(4):830-8. PubMed ID: 21920889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
